Management of supraglottic tumors using carbon dioxide laser
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20252248Keywords:
Supragglotis, Cancer, Larynx, CO2 LaserAbstract
Laryngeal cancer has a high mortality rate in Mexico and worldwide. Supraglottic cancer, in particular, accounts for many cases, and treatment varies based on the clinical stage of the disease, the medical center’s expertise, and the economic and human resources. A retrospective study was conducted between 2005 and 2023 on 14 patients with supraglottic squamous cell carcinoma. Most patients were male (85%), with an average age of 68.5 years, and the same percentage were smokers. Endoscopic carbon dioxide (CO2) laser resections were performed either alone, with induction chemotherapy, or as a salvage method following chemotherapy and radiotherapy. Laryngeal preservation was achieved in 92% of cases, with only one patient requiring total laryngectomy due to recurrence. Follow-up showed promising results, as most patients remained free of active disease for several years. Although some experienced local and regional recurrences, endoscopic CO2 laser surgery allowed for laryngeal preservation in many cases. Additionally, induction chemotherapy followed by endoscopic surgery also proved effective in advanced stages, yielding favorable oncological and functional outcomes. Endoscopic CO2 laser surgery is a reliable option for preserving the larynx in supraglottic cancer, even in advanced stages. Its oncological outcomes are comparable to those reported in the literature, offering a high rate of organ preservation and favorable long-term functional outcomes.
Metrics
References
Nocini R, Molteni G, Mattiuzzi C, Lippi G. Updates on larynx cancer epidemiology. Chin J Cancer Res. 2020;32(1):18-25. DOI: https://doi.org/10.21147/j.issn.1000-9604.2020.01.03
Herrera-Gómez A, Villavicencio-Valencia V, Rascón-Ortiz M, Luna-Ortiz K. Demographic data of laryngeal cancer at the Instituto Nacional de Cancerología in Mexico City. Cir Cir. 2009;77(5):353-7.
Dyckhoff G, Warta R, Herold-Mende C, Rudolph E, Plinkert PK, Ramroth H. An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment. Cancers. 2021;13:568. DOI: https://doi.org/10.3390/cancers13030568
Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116(9 Pt 2 Suppl 111):1-13. DOI: https://doi.org/10.1097/01.mlg.0000236095.97947.26
Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al; HEADSpAcE Consortium. Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 2024;10:e2300343. DOI: https://doi.org/10.1200/GO.23.00343
Gökmen MF, Büyükatalay ZÇ, Beton S, Gökcan MK, Dursun G, Meço C, et al. Functional and Oncological Outcomes of Open Partial Laryngectomy vs. Transoral Laser Surgery in Supraglottic Larynx Cancer. Turk Arch Otorhinolaryngol. 2020;58(4):227-33. DOI: https://doi.org/10.5152/tao.2020.5573
Thomas L, Drinnan M, Natesh B, Mehanna H, Jones T, Paleri V. Open conservation partial laryngectomy for laryngeal cancer: a systematic review of English language literature. Cancer Treat Rev. 2012;38(3):203-11. DOI: https://doi.org/10.1016/j.ctrv.2011.05.010
Ambrosch P, Gonzalez-Donate M, Fazel A, Schmalz C, Hedderich J. Transoral Laser Microsurgery for Supraglottic Cancer. Front Oncol. 2018;8:158. DOI: https://doi.org/10.3389/fonc.2018.00158
Gomez-Pedraza A, Luna-Ortiz K. Oncological approach for laryngeal cancer. J Cancerol. 2015;2:99-112.
Lechien JR. Surgical, Functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal Cancers: A systematic review. Oral Oncol. 2024;159:107047. DOI: https://doi.org/10.1016/j.oraloncology.2024.107047
Luna-Ortiz K, Mosqueda-Taylor A. Delphian lymph node in glottic carcinoma subjected to supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Cirugía y Cirujanos. 2005;73:7-10.
Luna-Ortiz K, Reynoso-Noveron N, Zacarias-Ramon LC, Alvarez-Avitia M, Luna-Peteuil Z, Garcia-Ortega DY. Supracricoid Partial Laryngectomy With and Without Neoadjuvant Chemotherapy in Glottic Cancer. Laryngoscope. 2022;132(1):156-62. DOI: https://doi.org/10.1002/lary.29713
Luna-Ortiz K, Gomez-Pedraza A, Garcia-Ortega DY, Pasche P. Supraglottic laryngectomy for endoscopic resection: proposal of a new classification. Int J Otorhinolaryngol Head Neck Surg. 2022;8(4):397-401. DOI: https://doi.org/10.18203/issn.2454-5929.ijohns20220810
Wünsch Filho V. The epidemiology of laryngeal cancer in Brazil. Sao Paulo Med J. 2004;122(5):188-94. DOI: https://doi.org/10.1590/S1516-31802004000500002
Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 1993;14(2):116-21. DOI: https://doi.org/10.1016/0196-0709(93)90050-H
García Lorenzo J, Montoro Martínez V, Rigo Quera A, Codina Aroca A, López Vilas M, Quer Agustí M, et al. Modifications in the treatment of advanced laryngeal cancer throughout the last 30 years. Eur Arch Otorhinolaryngol. 2017;274(9):3449-55. DOI: https://doi.org/10.1007/s00405-017-4639-z
Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for carcinoma of the supraglottic larynx. Otolaryngology–Head and Neck Surg. 2007;136:900-6. DOI: https://doi.org/10.1016/j.otohns.2006.12.015
Ambrosch P, Fazel A. Functional organ preservation in laryngeal and hypo-pharyngeal cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc02.
Chang CF, Wang LW, Yang MH, Chu PY. Induction chemotherapy followed by transoral laser microsurgery with or without adjuvant therapy for advanced hypopharyngeal cancer patients: A preliminary result. J Chin Med Assoc. 2024;19:38904335. DOI: https://doi.org/10.1097/JCMA.0000000000001121
Department of Veterans Affairs Laryngeal Cancer Study Group; Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685-90. DOI: https://doi.org/10.1056/NEJM199106133242402
Spector ME, Rosko AJ, Swiecicki PL, Chad Brenner J, Birkeland AC. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer. Oral Oncol. 2018;86:200-5. DOI: https://doi.org/10.1016/j.oraloncology.2018.09.026
Weiss BG, Bertlich M, Canis M, Ihler F. Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: Retrospective analysis of 199 cases. Head Neck. 2017;39(6):1166-76. DOI: https://doi.org/10.1002/hed.24737
Downloads
Published
How to Cite
Issue
Section
